Patient-reported outcome measures in patients with familial cerebral cavernous malformations: results from the Treat_CCM trial.

Mixed model analysis for the effect of propranolol on the development of the continuous MCS score over time showed a borderline significant interaction of treatment and time ( p = 0.065) (see Figure 2 ).

also in 11,409 other papers

78.2 ± 35.9, respectively); however, this did not reach statistical significance.

also in 111,027 other papers